- FDA eyes first schizophrenia drug shift in decades Axios
- Will 'Game Changer' Antipsychotic Live Up to the Hype? Medscape
- Schizophrenia Space Anticipates First-in-Class FDA Approval for BMS’ KarXT BioSpace
- Schizophrenia: the new drug set to tackle the ‘cancer of psychiatry’ Financial Times
- The 'game-changing' treatment for schizophrenia The Week
Thursday, September 26, 2024
FDA eyes first schizophrenia drug shift in decades - Axios
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment